Sartorius (OTCMKTS:SARTF) Short Interest Update

Sartorius (OTCMKTS:SARTF) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 2,451 shares, a growth of 213.8% from the June 15th total of 781 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 189 shares, the short-interest ratio is currently 13.0 days.

Sartorius Price Performance

Sartorius stock remained flat at $212.80 during midday trading on Monday. Sartorius has a 52-week low of $181.58 and a 52-week high of $227.00. The company has a current ratio of 0.95, a quick ratio of 0.49 and a debt-to-equity ratio of 0.89. The firm has a market capitalization of $7.28 billion, a PE ratio of 98.98 and a beta of 0.98. The firm has a fifty day simple moving average of $211.18 and a 200-day simple moving average of $220.58.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.